Coegin Pharma
  • About us
    • Management
    • Board of Directors
  • Our research
    • Platforms
    • Pipeline
    • Projects
      • Hair growth
      • Skin pigmentation
      • Leukemia
      • Myocardial infarction
  • Investor relations
    • Press releases
    • Financial reports
    • Financial calendar
    • The share
      • Shareholders
      • Warrants
    • Presentations
      • Analyses
    • Corporate governance
      • General meetings
      • Auditor
    • IR Contact
    • Archive
      • Offer documents
      • Previous IR Goldblue
  • Media
    • Video presentations
    • Press material
    • Press releases
  • Contact
  • Change language
    • English
    • Svenska

Analyses

23 augusti 2024
Redeye: Coegin Pharma Q2: Broadening the portfolio

Sign up for free to access Redeye's analyses.

  • Press releases
  • Financial reports
  • Financial calendar
  • The share
    • Shareholders
    • Warrants
  • Presentations
    • Analyses
  • Corporate governance
    • General meetings
    • Auditor
  • IR Contact
  • Archive
    • Offer documents
    • Previous IR Goldblue

Subscribe

Press releases and reports by email.

Subscribe

Receive press releases and reports to your e-mail.

Coegin Pharma AB

Registration number
559078-0465
Address
Coegin Pharma AB
c/o Medicon Village
223 81 Lund

Follow us

© Coegin Pharma AB

We use cookies. By continuing to use our website, you accept that cookies are used. Read more.

OK